Feedback / Questions
cannabidivarin/cannabigerolic acid (CNBX RCC-33) - CNBX Pharma
https://www.prnewswire.com/news-releases/cnbx-patent-application-composition-and-method-for-treating-cancer-with-cannabinoids-enters-national-phase-in-us-and-israel-301648446.html
Oct 13, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next